Treatment with Growth Hormone-Releasing Hormone Analog Reduces VEGFA, TGFβ1, and CSF1: Mechanisms of Tesamorelin Effect in Nonalcoholic Fatty Liver Disease

Conference Reports for NATAP

The Liver Meeting
Digital Experience
AASLD
November 13 - 16 - 2020


Treatment with Growth Hormone-Releasing Hormone Analog Reduces VEGFA, TGFβ1, and CSF1: Mechanisms of Tesamorelin Effect in Nonalcoholic Fatty Liver Disease

	AASLD 2020 Nov 11-16 virtual Lindsay T. Fourman, M.D.